The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Baseline characteristics of patients enrolled in the BERING CRC study: A European real-world study in BRAF V600E-mutant metastatic colorectal cancer.
 
Sebastian Stintzing
Honoraria - Amgen; Bayer; LEO Pharma; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; Sanofi; SERVIER; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; Sanofi; Sanofi; SERVIER; Takeda
Research Funding - Merck Serono (Inst); Pierre Fabre (Inst); Roche Molecular Diagnostics (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Lilly; Merck KGaA; Pierre Fabre; Roche; Sanofi; Sirtex Medical; Takeda
 
Gerdt Hübner
Honoraria - Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Alexion Pharmaceuticals; GlaxoSmithKline
 
Jan Schröder
Honoraria - Abbvie; Amgen; AOP Orphan Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology GmbH; Eisai; GlaxoSmithKline; HE Research GmbH; I+E Research; iOMEDICO; Ipsen; mediXline; MSD; NIO; Novartis; Octapharma USA; Pharma Partner; Roche; Searchlight Pharma
Other Relationship - American Society of Clinical Oncology; Arbeitskreis klinische Studien; BNHO; ESMO; German Cancer Society; German Society for Hematology and Medical Oncology; Wissenschaftliches Institut der Niedergelassenen Hämatologen und Onkologen
 
Helmut Forstbauer
Honoraria - Roche; Roche
 
Jens Kisro
Honoraria - Abbvie; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Novartis; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Janssen; Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Bristol-Myers Squibb; Janssen; Roche
 
Manfred Welslau
No Relationships to Disclose
 
Harald Müller-Huesmann
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Merck; MSD; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Merck; MSD; Roche; Seagen
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; Merck; MSD; Roche
 
Dieter Bürkle
Research Funding - Pierre Fabre (Inst)
 
Beate Krammer-Steiner
No Relationships to Disclose
 
Eyck von der Heyde
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
 
Frank Reichenbach
Employment - Pierre Fabre
 
Dirk Arnold
Employment - Asklepios Kliniken
Honoraria - Amgen; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb; Ipsen; Merck Serono; Merck Sharp and Dome; Pierre Fabre; Roche/Genentech; SERVIER
Consulting or Advisory Role - AstraZeneca; Bayer; Biocompatibles; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Terumo
Research Funding - Oncolytics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Boston Scientific
(OPTIONAL) Uncompensated Relationships - ESMO; ESMO Open; European Organisation for Research and Treatment of Cancer (EORTC); German Cancer Society; German Society for Hematology and Medical Oncology
 
Ralph M Fritsch
Honoraria - Bristol-Myers Squibb/Pfizer; MSD Oncology; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; Merck; MSD Oncology; Pierre Fabre
Speakers' Bureau - MSD Oncology; Pierre Fabre
Research Funding - Pierre Fabre
Travel, Accommodations, Expenses - Ipsen; Pierre Fabre; SERVIER
 
Armin Gerger
Honoraria - Pierre Fabre
Consulting or Advisory Role - Pierre Fabre
Speakers' Bureau - Pierre Fabre
 
Susanna Hegewisch-Becker
No Relationships to Disclose
 
Arndt Vogel
Honoraria - Advanced Accelerator Applications/Imaging Equipment Ltd; Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daichi-Sankyo; Incyte; Ipsen; Janssen; Lilly; MSD; Pierre Fabre; Roche; Sanofi; Sirtex Medical; TERUMO; TERUMO
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bayer; BTG; Daichi-Sankyo; Eisai; IPSEN; Lilly; Novartis; Pierre Fabre; Roche; Sirtex Medical; Terumo
Research Funding - Novartis
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Roche
 
Anna Dorothea Wagner
Consulting or Advisory Role - Alligator Bioscience; BMS (Inst); Dragonfly Therapeutics; Lilly; Merck KGaA; MSD Oncology; Servier/Pfizer
Speakers' Bureau - SERVIER
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Abbvie (Inst); MSD Oncology (Inst)
 
Thomas Winder
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; MSD; Pierre Fabre; Roche; SERVIER; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Merck; MSD; Pierre Fabre; Roche; SERVIER; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; MSD; Roche; SERVIER
 
Dieter Koeberle
Employment - Claraspital Basel
Consulting or Advisory Role - Pierre Fabre (Inst)
Speakers' Bureau - Pierre Fabre (Inst)
 
Gerald Prager
Consulting or Advisory Role - Amgen; Bayer; Daiichi Sankyo Europe GmbH; Incyte; Lilly; Merck Serono; Pierre Fabre; Roche/Genentech; SERVIER